Evaluating glioma therapies: Modeling treatments and predicting outcomes

Journal of the National Cancer Institute

Volumn 87, Issue 24, 1995, Pages 1884-1888

  Kirby, Sarah ^a   Brothers, Michael ^b   Irish, William ^c   Florell, Randall ^a   Macdonald, David ^a   Schold, Clifford ^d   Cairncross, Gregory ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; NITROSOUREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLIOBLASTOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; PREDICTION; PROGNOSIS;

ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; CARMUSTINE; CHILD; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMAN; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGE; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 0028786046     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.24.1884     Document Type: Article

References (14)

1. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980; 30:907-11.
2. Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992; 76:772-81.
3. Shapiro WR, Green S, Burger P, Selker R, Van Glider J, Saris S, et al. A randomized trial of interstitial radiotherapy (IRT) boost for the treatitKnt of newly diagnosed malignant glioma (glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma malignant mixed glioma): BTCG Study 8701. Neurology 1994;44 Suppl 2:A263.
4. Floren RC, Macdonald DR, Irish WD, Bernstein M, Leibel SA, Gatin PH, et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 1992;76:179-83.
5. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-10.
6. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-Brain Tumor Treatment Group [see comment citation in Medline]. Lancet 1995; 345:1008-12.
7. Patchell RA, Young AB, Ashton P. A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme. Neurology 1995;45 Suppl 4:A261.
8. Winger MJ, Macdonald DR, Schold SC Jr, Caimeross JG. Selection bias in clinical trials of anaplastic glioma. Ann Neurol 1989;26:531-4.
9. Recht L, Fram RJ, Strauss G, Fitzgerald TJ, Liepman M, Lew R, et al. Perirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis- platinum (CDDP) and i.v. BCNU. A phase II trial. Am J Clin Oncol 1990;13:125-31.
10. Dropcho EJ, Rosenfeld SS, Morawetz RB, Vitek J, Brothers M, Gorum T, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. J Clin Oncol 1992;10:452-8.
11. Fauchon F, Davila L, Chatellier G, Fohanno D, Philippon J, Rey A, et al. Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethyl- nitrosourea, and radiation therapy: a phase II smdy. Neurosurgery 1990; 27:231-4.
12. Madajewicz S, Chowhan N, Iliya A, Roque C, Beaton R, Davis R, et al. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer 1991;67:2844-9.
13. Bobo H, Kapp JP, Vance R. Effect of intraarterial cisplatin and 1,3-bis(2chloroethyl)-1- nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation. J Neurooncol 1992;13:291-9.
14. Dickson ER, Murtaugh PA, Weisner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103:1893-901.